Establishment of stable or drug resistant cell lines

JK JiHoon Kang
JC Jaemoo Chun
JH Jung Seok Hwang
CP Chaoyun Pan
JL Jie Li
AB Austin C. Boese
IY Isabelle Young
CM Courteney M. Malin
YK Yibin Kang
DG Don L. Gibbons
GS Gabriel Sica
HF Haian Fu
SR Suresh S. Ramalingam
LJ Lingtao Jin
SK Sumin Kang
request Request a Protocol
ask Ask a question
Favorite

Lentivirus production and infection for RSK2, GDH1, or CREB knockdown in human cancer cell lines were performed as previously described.30 Cells were transduced with retroviral vectors harboring GDH1 WT or Y135F followed by 300 mg/mL hygromycin selection for stable expression, and GFP-luciferase genes for bioluminescent imaging. HCC827 and PC9 erlotinib or osimertinibresistant cell lines were generated by culturing parental cells with escalating doses of erlotinib or osimertinib. The resistant cell lines were maintained in 1 μM of erlotinib or osimertinib, which were removed from the media for 1 day before conducting experiments.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A